Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 9 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

22%

2 trials in Phase 3/4

Results Transparency

0 of 4 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

Phase 1

4(44.4%)

Phase 2

3(33.3%)

Phase 3

2(22.2%)

9Total

Phase 1(4)

Phase 2(3)

Phase 3(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT07450482Phase 2Completed

Safety and Efficacy of JKN2304 Inhalation Solution in Patients With Moderate to Severe COPD

Role: lead

NCT07447141Phase 1Completed

DBM-1152A Inhalation Solution in Chinese Healthy Subjects

Role: lead

NCT07439419Phase 1Completed

DBM-1152A Inhalation Solution in Healthy Volunteers

Role: lead

NCT07440524Phase 2Active Not Recruiting

A Phase 2 Trial of JKN24011 in COPD

Role: lead

NCT07412938Phase 1Completed

JKN2306 in Healthy Subjects: Single Ascending Dose and Food Effect Study

Role: lead

NCT07357051Phase 3Recruiting

Phase III Clinical Study Evaluating the Safety, Pharmacokinetics, and Efficacy of JKN2301 Dry Suspension in Pediatric Patients Aged 2 to Under 12 Years With Influenza

Role: lead

NCT07351734Phase 2Recruiting

A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Trial of JKN2403 in COPD

Role: lead

NCT07330310Phase 3Not Yet Recruiting

A Phase 3 Trial of JKN2401 Injection in COPD

Role: lead

NCT07207291Phase 1Recruiting

Phase I Study of Single/Multiple Ascending Doses of JKN2501 for Injection in Chinese Healthy Volunteers

Role: lead

All 9 trials loaded